These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 24146262)

  • 1. Noncoding RNAs in prostate cancer: the long and the short of it.
    Bolton EM; Tuzova AV; Walsh AL; Lynch T; Perry AS
    Clin Cancer Res; 2014 Jan; 20(1):35-43. PubMed ID: 24146262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the function of non-coding RNAs in prostate cancer.
    Ramalho-Carvalho J; Fromm B; Henrique R; Jerónimo C
    Cancer Metastasis Rev; 2016 Jun; 35(2):235-62. PubMed ID: 27221068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular RNA interference therapy: the broadening tool and target spectrum.
    Poller W; Tank J; Skurk C; Gast M
    Circ Res; 2013 Aug; 113(5):588-602. PubMed ID: 23948584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNAs: new players in prostate cancer.
    Cheng W; Zhang Z; Wang J
    Cancer Lett; 2013 Oct; 339(1):8-14. PubMed ID: 23856029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
    Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
    Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Non-Coding Transcriptome of Prostate Cancer: Implications for Clinical Practice.
    Bijnsdorp IV; van Royen ME; Verhaegh GW; Martens-Uzunova ES
    Mol Diagn Ther; 2017 Aug; 21(4):385-400. PubMed ID: 28299719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.
    Gordanpour A; Nam RK; Sugar L; Seth A
    Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting high-risk disease using tissue biomarkers.
    Donovan MJ; Cordon-Cardo C
    Curr Opin Urol; 2013 May; 23(3):245-51. PubMed ID: 23478499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of prostate cancer: clinical translational opportunities.
    Vecchione A; Gottardo F; Gomella LG; Wildemore B; Fassan Ms; Bragantini E; Pagano F; Baffa R
    J Exp Clin Cancer Res; 2007 Mar; 26(1):25-37. PubMed ID: 17550130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
    Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
    Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H
    Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of noncoding RNA in prostate cancer progression and its implication on diagnosis and treatment.
    Takayama K; Inoue S
    Brief Funct Genomics; 2016 May; 15(3):257-65. PubMed ID: 26685282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic biomarkers in prostate cancer: Current and future uses.
    Chiam K; Ricciardelli C; Bianco-Miotto T
    Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncoding RNA for personalized prostate cancer treatment: utilizing the 'dark matters' of the genome.
    Hua J; Lu J; Isaev K; Soares F; Guo H; Ahmed M; He HH
    Per Med; 2017 Mar; 14(2):159-169. PubMed ID: 29754555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNA in bladder cancer: a specific focus upon high-risk nonmuscle invasive disease.
    Noon AP; Catto JW
    Curr Opin Urol; 2014 Sep; 24(5):506-11. PubMed ID: 25051024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling transcription with noncoding RNAs in mammalian cells.
    Turner AM; Morris KV
    Biotechniques; 2010 Jun; 48(6):ix-xvi. PubMed ID: 20569216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of expression profiling of circulating microRNAs in men with prostate cancer.
    Kelly BD; Miller N; Healy NA; Walsh K; Kerin MJ
    BJU Int; 2013 Jan; 111(1):17-21. PubMed ID: 22612403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of microRNAs in prostate cancer: implications for personalized medicine.
    Gandellini P; Folini M; Zaffaroni N
    Discov Med; 2010 Mar; 9(46):212-8. PubMed ID: 20350487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncoding RNAs in molecular characterization of cancer preneoplasia.
    Wang W; Srivastava S
    Cancer Biomark; 2010; 9(1-6):133-40. PubMed ID: 22112473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer.
    Martens-Uzunova ES; Jalava SE; Dits NF; van Leenders GJ; Møller S; Trapman J; Bangma CH; Litman T; Visakorpi T; Jenster G
    Oncogene; 2012 Feb; 31(8):978-91. PubMed ID: 21765474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.